Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-2.25 Insider Own2.30% Shs Outstand340.45M Perf Week-4.24%
Market Cap39.59B Forward P/E12.18 EPS next Y9.54 Insider Trans6.88% Shs Float325.68M Perf Month2.17%
Income-746.30M PEG- EPS next Q1.97 Inst Own66.80% Short Float4.04% Perf Quarter-4.07%
Sales7.53B P/S5.26 EPS this Y-610.50% Inst Trans20.73% Short Ratio5.34 Perf Half Y-11.55%
Book/sh15.68 P/B7.42 EPS next Y19.27% ROA-2.70% Target Price52.38 Perf Year11.37%
Cash/sh1.56 P/C74.52 EPS next 5Y17.64% ROE-14.60% 52W Range102.30 - 153.10 Perf YTD-0.95%
Dividend- P/FCF40.37 EPS past 5Y-33.00% ROI-0.10% 52W High-24.05% Beta0.94
Dividend %- Quick Ratio1.70 Sales past 5Y50.10% Gross Margin68.00% 52W Low13.67% ATR2.69
Employees17200 Current Ratio2.10 Sales Q/Q86.30% Oper. Margin16.10% RSI (14)41.25 Volatility2.29% 2.16%
OptionableYes Debt/Eq3.30 EPS Q/Q1064.80% Profit Margin-9.90% Rel Volume0.83 Prev Close117.43
ShortableYes LT Debt/Eq3.24 EarningsMay 08 BMO Payout- Avg Volume2.47M Price116.28
Recom3.00 SMA20-2.39% SMA50-1.28% SMA200-7.84% Volume2,054,008 Change-0.98%
28-Feb-14Reiterated UBS Buy $141 → $170
28-Feb-14Reiterated RBC Capital Mkts Outperform $151 → $158
27-Feb-14Reiterated Aegis Capital Buy $160 → $180
08-Jan-14Reiterated UBS Buy $125 → $141
08-Jan-14Reiterated Ladenburg Thalmann Buy $123 → $155
08-Jan-14Reiterated FBR Capital Outperform $130 → $153
03-Dec-13Reiterated UBS Buy $115 → $125
01-Nov-13Reiterated Ladenburg Thalmann Buy $127 → $123
30-Oct-13Initiated FBR Capital Outperform $130
07-Oct-13Reiterated CRT Capital Buy $110 → $130
08-Aug-13Reiterated UBS Buy $96 → $115
07-Aug-13Reiterated Aegis Capital Buy $135 → $140
02-Jul-13Reiterated RBC Capital Mkts Outperform $76 → $100
10-Jun-13Upgrade CRT Capital Hold → Buy $100
29-May-13Reiterated Ladenburg Thalmann Buy $84 → $124
29-May-13Reiterated Deutsche Bank Buy $82 → $103
03-May-13Reiterated Deutsche Bank Buy $80 → $82
04-Apr-13Reiterated UBS Buy $83 → $81
04-Apr-13Reiterated RBC Capital Mkts Outperform $80 → $76
21-Mar-13Reiterated Deutsche Bank Buy $77 → $83
22-Sep-14 08:06PM  Obama Administration Moves To Try Stop Companies From Leaving America at Forbes
06:56PM  Botox Maker Allergan Said to Be in Talks to Acquire Salix at New York Times
19-Sep-14 01:04PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials EDGAR Online Financials
18-Sep-14 05:01PM  Must-know: Eminence Capital sells its stake in Valmont Industries Market Realist
04:05PM  Allergan-Valeant Fight Holds Lessons for All Corporate Shareholders at New York Times
01:19PM  Valeant's Improving Stock Price Makes its Allergan Bid Look Better at The Wall Street Journal
01:01PM  Must-know: Eminence Capital exits a position in Qualcomm Market Realist
09:00AM  Must-know: Eminence Capital starts a new position in Baidu Market Realist
17-Sep-14 05:23PM  Eminence Capital has a new position in Valeant Pharmaceuticals Market Realist
05:00PM  Steven Cohens Point72 Asset Management cuts its stake in Baidu Market Realist
01:23PM  Eminence Capital adds a new position in Madison Square Garden Market Realist
01:00PM  Point72 Asset Management reduces a large stake in Yahoo Market Realist
12:04PM  Valeants Last Shot to Woo Owners of Botox Maker Allergan at New York Times
09:22AM  Overview: Eminence Capitals key 2Q14 positions Market Realist
16-Sep-14 05:00PM  Point72 ups its position in Valeant Pharmaceuticals in 2Q14 Market Realist
01:00PM  Point72 Asset Management increases its stake in Whiting Petroleum Market Realist
11:57AM  Allergan, Pershing Square Settle: Now What? at Barrons.com
11:36AM  Video: Valeant, Allergan Settle Suit, Allow Shareholder Vote at Investor's Business Daily
11:36AM  Valeant, Allergan Settle Suit, Allow Shareholder Vote at Investor's Business Daily
09:42AM  Faber Report: Allergan special meeting CNBC
09:00AM  Point72 Asset Management adds to its position in Baker Hughes Market Realist
08:34AM  Tigers Chopra Stumbles in Rise to Top Robertson Empire Bloomberg
07:18AM  Allergan agrees to move forward with meeting AP
06:35AM  Allergan agrees to move forward with meeting AP
12:57AM  Botox Maker Allergan Agrees to Hold Meeting That Could Lead to Takeover at New York Times
12:57AM  Allergan Agrees to Hold Meeting That Could Lead to Takeover at New York Times
15-Sep-14 08:03PM  Tigers Chopra Stumbles in Rise to Top Robertson Empire at Bloomberg
05:00PM  Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 PR Newswire
05:00PM  Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 CNW Group
03:57PM  Steven Cohen and Point72 Asset Managements 2Q 2014 positions Market Realist
12:22PM  Ackman's New Fund Could Spur More Market Activism at Investor's Business Daily
04:30AM  Ackman plans Amsterdam fund IPO in Europe push at CNBC
12:00AM  Latisse Appeal, Scottish Web: Intellectual Property at Bloomberg
12-Sep-14 04:25PM  Will Allergan's Board Be Revamped to Aid Valeant Buyout? Zacks
12:20PM  Midday movers: eBay, Sprint, Yahoo & more at CNBC
11-Sep-14 11:05AM  Allergan vs. Valeant: Where's Perry Mason When You Need Him? at Barrons.com
09:38AM  [video] Faber Report: Valeant submits consents at CNBC
10-Sep-14 12:00AM  Ubben Returns 17% Shaking Boardrooms as He Backs Tax Inversions Bloomberg
12:00AM  Tax Inversion Pioneer Shakes Boardrooms With 17% Return Bloomberg
12:00AM  Inversion Pioneer Ubben Delivers 17% as Quiet Activist at Bloomberg
09-Sep-14 03:48PM  In Letter to Botox Maker, Ackman Attacks Board Inaction on Merger Talks at New York Times
08-Sep-14 05:00PM  Valeant Pharmaceuticals Expands Bausch + Lomb Manufacturing Facility, Adding 120 New Jobs in Rochester PR Newswire
05:00PM  Valeant Pharmaceuticals Expands Bausch + Lomb Manufacturing Facility, Adding 120 New Jobs in Rochester CNW Group
05-Sep-14 05:06PM  Salix, Gilead Among 5 Top Medical Leaders To Watch at Investor's Business Daily
10:37AM  Allergan OKs Special Shareholder Meeting Consents at TheStreet
04-Sep-14 09:49PM  Most Held Canadian Stocks of the Second Quarter Gurufocus
09:41AM  [video] Faber Report: Allergan special meeting coming at CNBC
02-Sep-14 01:03PM  Today's Top Performers In Drugs at TheStreet
28-Aug-14 03:40PM  Allergan Seeks Court Order to Stop Valeant, Affiliates Zacks
01:04PM  VALEANT PHARMACEUTICALS INTERNATIONAL Financials EDGAR Online Financials
06:53AM  [video] Legal Victory for Ackman and Valeant Pharma at Bloomberg
12:00AM  Allergan Attempts to Elude Ackman Bid Fuel Bearish Bets at Bloomberg
27-Aug-14 02:48PM  Allergan sets date for special shareholder meeting AP
01:22PM  Allergan v Valeant: When Will It End? at Barrons.com
01:04PM  VALEANT PHARMACEUTICALS INTERNATIONAL Financials EDGAR Online Financials
08:02AM  Gilead, Jazz Among 4 Top Big Cap Medicals To Watch at Investor's Business Daily
07:15AM  US STOCKS-Futures slightly higher with indexes at records Reuters
26-Aug-14 05:47PM  Botox Maker Allergan Sets Date for Special Shareholder Meeting at New York Times
02:08PM  [video] Allergan to announce special meeting later today at CNBC
12:36PM  Canada, the Accidental Tax Haven at BusinessWeek
25-Aug-14 10:04PM  Allergan, Inc. -- Moody's: Special meeting process is credit negative for Allergan at Moody's
08:38PM  Ackman Gains 30% With Burger King, Herbalife Wagers Bloomberg
01:04PM  TEVA, VRX And AGN, Pushing Drugs Industry Downward at TheStreet
01:00PM  Allergan v. Valeant: Here Comes the Lawsuit at Barrons.com
10:59AM  Pershing Square Delivers Votes For Allergan Special Meeting to Push Valeant Deal at TheStreet
07:33AM  Early movers: BKW, ANN, BBRY, ITMN, GS, SNE & more at CNBC
05:54AM  PRESS DIGEST- Canada - Aug 25 Reuters
23-Aug-14 02:29PM  Allergan reviews meeting requests in takeover bid AP
22-Aug-14 05:45PM  Valeant and Pershing Square Say They Have Votes for Special Meeting of Botox Maker Allergan at New York Times
05:45PM  Valeant and Pershing Square Said to Have Votes for Special Meeting of Botox Maker Allergan at New York Times
12:58PM  Midday movers: Angie's List, Deere, McDonald's & more at CNBC
10:59AM  How Will Allergan (AGN) Stock Respond To Special Shareholders Meeting Request By Valeant (VRX), Pershing Square? at TheStreet
09:31AM  [video] Valeant's special meeting at CNBC
08:10AM  These 5 Toxic Stocks Could Be Poisoning Your Portfolio at TheStreet
21-Aug-14 06:05PM  Botox Maker Allergans Suit Against Valeant Wont Delay Special Meeting at New York Times
05:34PM  Quick Gainers Also Have Trouble Advancing In Hesitant Market Investor's Business Daily
20-Aug-14 03:45PM  Salix Pharmaceuticals Jumps on Takeover Rumours by Allergan Zacks
01:04PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials EDGAR Online Financials
12:52PM  In the Eye of the Beholder: Dueling Descriptions in Allergan, Valeant Suits at The Wall Street Journal
09:38AM  [video] Faber Report: WSJ says Allergan approaches Salix at CNBC
08:38AM  Hedge funds love health care, hate media stocks at CNNMoney.com
19-Aug-14 07:06PM  Video: Allergan May Seek Salix Deal To Avoid Valeant at Investor's Business Daily
03:01PM  Why Salix Pharmaceuticals (SLXP) Stock Is Soaring Today at TheStreet
02:28PM  Video: Allergan May Seek Salix Deal To Avoid Valeant at Investor's Business Daily
02:28PM  Allergan Reportedly Eyes Salix To Avoid Valeant Deal at Investor's Business Daily
01:04PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials EDGAR Online Financials
12:47PM  Big Allergan Shareholders Pare Stakes as Valeant, Ackman Press Bid at The Wall Street Journal
18-Aug-14 03:48PM  Allergan: When Your CFO Leaves for 'Family Reasons' at Barrons.com
01:12PM  Allergan names Hindman chief financial officer AP
12:57PM  Midday movers: Apple, Fabrinet, Lear & more at CNBC
12:32PM  Fight for Maker of Botox Tests Scope of Insider Trading Laws at New York Times
10:56AM  Why Valeant (VRX) Stock Is Lower Today at TheStreet
10:31AM  Allergan names company veteran Hindman CFO Reuters
16-Aug-14 03:29AM  [$$] Review at Barrons.com
03:29AM  [$$] Last Week at Barrons.com
15-Aug-14 05:00PM  Valeant Extends Offer To Acquire Allergan PR Newswire
05:00PM  Valeant Extends Offer To Acquire Allergan CNW Group
01:51PM  IRS to probe Valeant tax returns after Canada deal at Financial Times
01:20PM  Allergan Takes In 13 New Hedge Fund Investments In Q2 Benzinga
09:39AM  [video] Faber Report: Allergan shareholder shift at CNBC
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. Its pharmaceutical products include Solodyn, an oral antibiotic that treats red and pus-filled pimples, as well as Ziana, Acanya, and Atralin; Wellbutrin XL, a formulation used for the treatment of major depressive disorder in adults; Xenazine for the treatment of chorea; Zovirax Cream for herpes labialis; Zovirax ointment for initial genital herpes; The Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; and Prolensa, a non-steroidal anti-inflammatory ophthalmic solution. The company also provides OTC products, such as PreserVision, an antioxidant eye vitamin and mineral supplement; ReNu Multiplus, a sterile that is used to lubricate and rewet soft contact lenses; Ocuvite, a lutein eye vitamin and mineral supplement; Artelac, an eye drops to treat dry eyes; and CeraVe products for skin. In addition, it offers device products, including SofLens daily disposable contact lenses; Restylane, an injectable implant dermal fillers; PureVision, a contact lens; Dysport, an injection neurotoxin; ophthalmic surgical products, such as Akreos and Crystalens; surgical equipment comprising the VICTUS femtosecond laser and the Stellaris PC, a vitreoretinal and cataract surgery system; and medical device systems for aesthetic applications. Further, it provides generic products comprising Retin-A Micro, a tretinoin gel; tobramycin and dexamethasone ophthalmic suspensions for steroid responsive inflammatory ocular conditions; and latanoprost to treat glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stolz Brian M.EVP, CHCO and AdministrationAug 06Option Exercise0.0018,111079,431Aug 07 03:53 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Jun 23Option Exercise6.4510,20365,80934,202Jun 24 04:37 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Jun 23Sale121.7010,2031,241,67623,999Jun 24 04:37 PM
Mirovsky PavelPresident of Valeant EuropeJun 02Sale131.2510,0001,312,4860Jun 04 03:19 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.May 13Option Exercise6.4510,00064,50033,999May 14 04:29 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.May 13Sale130.0810,0001,300,83623,999May 14 04:29 PM
Provencio Norma AnnDirectorApr 01Sale132.185,000660,886137,495Apr 02 04:55 PM
Kornwasser LaizerEVP, Company Group ChairmanMar 21Buy134.972,481334,85953,582Mar 25 01:06 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Mar 17Option Exercise6.455,00032,25028,999Mar 19 04:33 PM
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy.Mar 17Sale141.725,000708,60023,999Mar 19 04:33 PM
Weldon RyanEVP, Company Group ChairmanFeb 11Option Exercise0.0011,0000103,823Feb 12 04:43 PM
Stolz Brian M.EVP, Administration & CHCOFeb 11Option Exercise0.0014,700069,783Feb 12 04:08 PM
Schiller Howard BradleyEVP, CFOFeb 11Option Exercise0.0090,0000312,704Feb 12 03:51 PM
Kornwasser LaizerEVP, Company Group ChairmanFeb 11Option Exercise0.0045,000073,390Feb 12 03:34 PM
Provencio Norma AnnDirectorFeb 03Sale136.235,000681,158147,206Feb 04 06:15 PM
Weldon RyanEVP, Company Group ChairmanJan 24Option Exercise0.0019,0000101,539Jan 28 05:09 PM
Mirovsky PavelPresident of Valeant EuropeJan 24Option Exercise0.0010,000010,000Jan 28 05:00 PM
Kornwasser LaizerEVP, Company Group ChairmanJan 24Buy132.152,536335,12828,390Jan 28 04:51 PM
Stolz Brian M.EVP, Administration and CHCOJan 20Option Exercise0.0045,000077,939Jan 22 04:55 PM